Addiction Opiate Clinical Trial
Official title:
Comparing the Effect of Cognitive Behavioral Therapy, Mindfulness Based Relapse Prevention and Twelve-step Therapy in Patients With Opioid Craving
Verified date | February 2022 |
Source | Alexandria University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
the study aim is to compare betwenn the effect of mindfulness based relapse prevention and other evidence based psychotherapy interventions regaring substance craving.
Status | Completed |
Enrollment | 45 |
Est. completion date | October 10, 2021 |
Est. primary completion date | June 30, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 15 Years to 50 Years |
Eligibility | Inclusion Criteria: - Age: 15-50 years. - Male gender. - Patients meet DSM-5(3) criteria of opioid abuse. - Had completed detoxification in a treatment center. - Willing to give consent they will be randomly assigned to either CBT, MBRP, or twelve-step treatment group. - Patients have dual diagnoses. - Patients have poly-substance use disorder. Exclusion Criteria: - Participants with significant cognitive disorder. - Participants with suicidal thoughts. - Participants with any organic condition affecting stress response and so craving such as hypertension, respiratory or cardiovascular disorders. - Participants taking any medications (e.g., antipsychotics in high doses) known to affect the stress response. - Participants relapsed to drug abuse during therapy. |
Country | Name | City | State |
---|---|---|---|
Egypt | Sara Harby | Alexandria |
Lead Sponsor | Collaborator |
---|---|
Sara Harby |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | opioid craving scale | A visual analog scale, a modification of the Cocaine Craving Scale, is a 3-item scale used to measure the opioid craving and each item is ranging from 0 to 10 (0 means no craving at all and 10 means severe craving). | 5 minutes | |
Secondary | The Obsessive-Compulsive Drug use Scale | it measures craving in the previous ten days and includes 13 questions. Subjects should select from 5 graded options for each question based on their experiences during last week. The items were rated as follow:1) Never; 2) Rarely; 3) Sometimes; 4) Mostly and 5) Always | 15 minutes | |
Secondary | The desire for a drug questionnaire | it measures instant (now) craving, includes 14 questions and participants answer questions on a seven-step Likert-scale answer sheet based on what he/she feels or thinks at the moment. The items were rated as follows: 1) not at all; 2) mild; 3) mild to moderate; 4) moderate; 5) moderate to severe; 6) severe and 7) approximately complete | 15 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05361603 -
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
|
||
Recruiting |
NCT03952455 -
Deep Brain Stimulation of the Bilateral Nucleus Accumbens for Patients With Methadone Maintenance Treatment
|
N/A | |
Recruiting |
NCT06266039 -
Introduction of Long Acting Buprenorphine in France
|
||
Recruiting |
NCT05161351 -
Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence.
|
Phase 4 | |
Withdrawn |
NCT04464512 -
Suboxone User Perioperative Early Referral and Enhanced Recovery After Surgery- Orthopaedic Trauma Surgery Population
|
Phase 4 | |
Completed |
NCT05431985 -
Cross-cultural Validation of a Screening Scale for the Misuse of Opioid Analgesics in Primary Care
|